Nathan Papa

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer”.

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer

Frontiers in Oncology(2022)10.3389/fonc.2022.929444

N/A

0.434DataRank · unranked

17 citations

Arthur Yim, Nathan Papa, Shankar Siva, Joseph Ischia, Karim Touijer +4 more

A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.08.012

N/A

0DataRank · unranked

6 citations

Marlon Perera, Jonathan G. Bensley, Melanie Evans, Jeremy Millar, Mark Frydenberg +3 more

The BJUI Editorial Team's view on artificial intelligence and machine learning

British Journal of Urology(2023)10.1111/bju.16024

N/A

0DataRank · unranked

5 citations

Tobias Klatte, Nathan Papa, Sigrid Carlsson, George N. Thalmann

Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.013

N/A

0DataRank · unranked

6 citations

Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram, Phillip M. Rappold +7 more